ChemicalBook Product Catalog Biochemical Engineering Inhibitors PI3K / Akt / mTOR PI3K inhibitor GSK2636771

GSK2636771

GSK2636771 Basic information
Product Name:GSK2636771
Synonyms:GSK2636771;2-Methyl-1-[[2-Methyl-3-(trifluoroMethyl)phenyl]Methyl]-6-(4-Morpholinyl)-1H-benziMidazole-4-carboxylic acid;GSK2636771/GSK-2636771;GSK 2636771 dihydrochloride;2-Methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic;1H-Benzimidazole-4-carboxylic acid, 2-methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-;2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid GSK2636771;2-METHYL-1-[[2-METHYL-3-(TRIFLUOROMETHYL)PHENYL]METHYL]-6-MORPHOLIN-4-YLBENZIMIDAZOLE-4-CARBOXYLIC ACID
CAS:1372540-25-4
MF:C22H22F3N3O3
MW:433.42
EINECS:
Product Categories:Inhibitors;PI3K/Akt/mTOR;Akt;mTOR;PI3K;api;1372540-25-4
Mol File:1372540-25-4.mol
GSK2636771 Structure
GSK2636771 Chemical Properties
Melting point >225°C (dec.)
Boiling point 641.3±55.0 °C(Predicted)
density 1.38
storage temp. -20°C Freezer
solubility DMSO (Slightly), Methanol (Slightly)
pka-2.70±0.30(Predicted)
form Solid
color Pale Yellow
Safety Information
MSDS Information
GSK2636771 Usage And Synthesis
UsesGSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, sensitive to PTEN null cell lines.
GSK2636771 Preparation Products And Raw materials
GSK-3326595 Lp-PLA2 -IN-1 GSK 2239633A GSK-2018682 gsk2200150a CAL-101 IPI 145 Pictilisib GSK-2881078 Alpelisib (BYL719) MethanesulfonaMide, N-[5-[4-[5-[[(2R,6S)-2,6-diMethyl-4-Morpholinyl]Methyl]-2-oxazolyl]-1H-indazol-6-yl]-2-Methoxy-3-pyridinyl]-, rel- GSK2982772 GSK369796 AZD6482 GSK-2256098 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide GSK2126458 Bortezomib
Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.